Multiple Effects of Somatostatin Analogs Verified in Three Cases of Metastasized Neuroendocrine Tumors of the Gastroenteropancreatic System

Tumori - Italy
doi 10.1177/030089160609200214
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Prognostic Significance of AKT/mTOR Signaling in Advanced Neuroendocrine Tumors Treated With Somatostatin Analogs

OncoTargets and Therapy
OncologyPharmacology
2012English

Incidence Trends of Gastroenteropancreatic Neuroendocrine Tumors in the United States

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2019English

MicroRNA Analysis of Gastroenteropancreatic Neuroendocrine Tumors and Metastases

Oncotarget
Oncology
2018English

Resistance to Targeted Treatment of Gastroenteropancreatic Neuroendocrine Tumors

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2019English

Identification of Primary Tumors in Patients Presenting With Metastatic Gastroenteropancreatic Neuroendocrine Tumors

Surgery
Surgery
2017English

Presence and Clinical-Histological Correlates of Ghrelin and Somatostatin Systems Components in Gastroenteropancreatic Neuroendocrine Tumors and Lung Carcinoids

Endocrine Abstracts
2016English

Role of Somatostatin Analogues in the Treatment of Neuroendocrine Tumors

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2015English

Circulating Markers in Gastroenteropancreatic Neuroendocrine Tumors (GEP NETs)

2012English

Catecholamine Production in Patients With Gastroenteropancreatic Neuroendocrine Tumors

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy